Fox Run Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Fox Run Management's PFE Position: Q3 2025 in Review
Fox Run Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 36,851 shares — an estimated $893K sold.
Fox Run Management first reported a position in PFE in Q2 2016 and held it in 17 quarters. The position peaked at $3M in Q1 2025. 2,817 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- Fox Run Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
- Fox Run Management sold 36,851 Pfizer shares in Q3 2025, an estimated $893K.
- Fox Run Management first reported a position in Pfizer in Q2 2016 and held it in 17 quarters.
- Fox Run Management's Pfizer position peaked at $3M in Q1 2025.
- 2,817 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on Fox Run Management's 13F filing for Q3 2025, filed 12 Nov 2025.